Ritonavir D8
| Product Name | Ritonavir D8 |
|---|---|
| Alternate Names | Ritonavir Stable Isotopes, Stable Isotopes of Ritonavir |
| CAT No. | CS-O-02715 |
| CAS No. | 155213-67-5(Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 728.99 g/mol |
| Mol. For. | C₃₇H₄₀D₈N₆O₅S₂ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Ritonavir |
| Purity | 95% |
| Therapeutic | Antiretroviral / Anti-HIV |
| Smileys | O=C(N(CC1=CSC(C(C)C)=N1)C)NC(C(N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@@H](NC(OCC3=CN=CS3)=O)CC4=CC=CC=C4)O)=O)([2H])C(C([2H])([2H])[2H])([2H])C([2H])([2H])[2H] |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Ritonavir D8 is a deuterated form of the antiviral drug Ritonavir, which is used for the treatment of HIV (Human Immunodeficiency Virus) infection. Ritonavir D8 is labeled with eight deuterium atoms, which makes it useful for pharmacokinetic studies and drug metabolism research.
Ritonavir D8 is a protease inhibitor that works by blocking the activity of the HIV protease enzyme, which is essential for the replication of the virus. By inhibiting the protease enzyme, Ritonavir D8 prevents the virus from multiplying and spreading throughout the body.
The chemical formula of Ritonavir D8 is C37H47D8N5O4S2, and its molecular weight is 747.08 g/mol. The drug is administered orally in the form of a tablet, capsule, or solution. The recommended dose of Ritonavir D8 is usually based on the patient's weight and medical condition, and it is usually taken with other antiretroviral drugs for maximum effectiveness.
Ritonavir D8 may cause side effects such as nausea, vomiting, diarrhea, headache, and changes in taste or appetite. It may also interact with other medications, so it is important to inform your healthcare provider about all the drugs you are taking before starting treatment with Ritonavir D8.
In conclusion, Ritonavir D8 is a deuterated form of Ritonavir that is used for research purposes and pharmacokinetic studies. It is an effective HIV protease inhibitor that helps to control the spread of the virus in the body. If you are prescribed Ritonavir D8, it is important to take it as directed by your healthcare provider and report any side effects or concerns immediately.
Get an Instant Quote
Related Compounds
Ritonavir D6 | Desthiazolylmethyloxycarbonyl Ritonavir-d6 | Ritonavir-13C3 | N-Nitroso Ritonavir Intermediate D6 |